|
GINS4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.988300E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.398400E-01 |
| Normal-vs-Stage2 |
3.095900E-02 |
| Normal-vs-Stage3 |
1.075960E-01 |
| Normal-vs-Stage4 |
1.501150E-01 |
| Stage1-vs-Stage2 |
1.522820E-01 |
| Stage1-vs-Stage3 |
3.866400E-01 |
| Stage1-vs-Stage4 |
5.011600E-01 |
| Stage2-vs-Stage3 |
4.576800E-01 |
| Stage2-vs-Stage4 |
5.286800E-01 |
| Stage3-vs-Stage4 |
9.846200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.330400E-01 |
| Normal-vs-AfricanAmerican |
7.504200E-01 |
| Normal-vs-Asian |
3.632300E-02 |
| Caucasian-vs-AfricanAmerican |
7.033200E-01 |
| Caucasian-vs-Asian |
1.504180E-01 |
| AfricanAmerican-vs-Asian |
2.750400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.493780E-01 |
| Normal-vs-Female |
1.669410E-01 |
| Male-vs-Female |
7.982600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.924800E-01 |
| Normal-vs-Age(41-60Yrs) |
9.004300E-03 |
| Normal-vs-Age(61-80Yrs) |
1.288960E-01 |
| Normal-vs-Age(81-100Yrs) |
9.404000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.998400E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.831180E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.115000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.034800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.962400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.300800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.345200E-01 |
| Classical-VS-Follicular |
7.407800E-02 |
| Classical-VS-Other |
2.389800E-01 |
| Classical-VS-Normal |
3.858600E-01 |
| Tall-VS-Follicular |
3.893600E-01 |
| Tall-VS-Other |
2.557200E-01 |
| Tall-VS-Normal |
3.083400E-01 |
| Follicular-VS-Other |
6.314200E-01 |
| Follicular-VS-Normal |
4.010300E-02 |
| Other-VS-Normal |
9.068100E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.689800E-02 |
| Normal-vs-N1 |
1.638790E-01 |
| N0-vs-N1 |
9.715400E-01 |
|
|
